Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma.

Autor: Eckmann J; Roche Innovation Center Munich, Germany., Fauti T; Roche Innovation Center Zurich, Switzerland., Biehl M; Roche Innovation Center Zurich, Switzerland., Zabaleta A; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicadas (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), Pamplona, Spain., Blanco L; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), Pamplona, Spain., Lelios I; Roche Innovation Center Basel, Switzerland., Gottwald S; Roche Innovation Center Munich, Germany., Rae R; Roche Innovation Center Munich, Germany., Lechner S; Roche Innovation Center Munich, Germany., Bayer C; Roche Innovation Center Munich, Germany., Dekempe Q; Roche Innovation Center Munich, Germany., Osl F; Roche Innovation Center Munich, Germany., Carrié N; centre de recherche en cancérologie de toulouse INSERM U1037, toulouse, France., Kassem S; Centre de rechecrche en cancérologie de Toulouse de Inserm U1037, Toulouse, France., Lorenz S; Roche Innovation Center Munich, Germany., Christopeit T; Roche Innovation Center Munich, Germany., Carpy A; Roche Innovation Center Munich, Germany., Bujotzek A; Roche Innovation Center Munich, Germany., Bröske AE; Roche Innovation Center Munich, Germany., Dekhtiarenko I; Roche Innovation Center Zurich, Switzerland., Attig J; Pharmaceutical Sciences, pRED, Switzerland., Kunz L; Roche Innovation Center Zurich, Switzerland., Cremasco F; Roche Innovation Center Zurich, Switzerland., Adelfio R; Roche Innovation Center Zurich, Switzerland., Fertig G; Roche Innovation Center Munich, Germany., Dengl S; Roche Innovation Center Munich, Germany., Gassner C; Roche Innovation Center Munich, Germany., Bormann F; Roche Innovation Center Munich, Germany., Kirstenpfad C; Roche Innovation Center Munich, Germany., Kraft TE; Pharmaceutical Sciences, pRED, Germany., Diggelmann S; Roche Innovation Center Zurich, Switzerland., Knobloch M; Roche Innovation Center Munich, Switzerland., Hage C; Roche Innovation Center Munich, Germany., Feddersen R; Roche Innovation Center Munich, Germany., Heidkamp G; Roche Innovation Center Munich, Germany., Pöschinger T; Roche Innovation Center Munich, Germany., Mayoux ML; University of Zurich, Zurich, Switzerland., Bernasconi L; Lonza, Basel, Switzerland., Dumontet C; Hospices Civils de Lyon, Lyon, France., Prosper F; Clinica Universidad de Navarra, Pamplona, Spain., Martinet L; CRCT, Toulouse, France., Leclair S; Roche Innovation Center Munich, Germany., Xu W; METiS Pharmaceuticals, Hangzhou, China., Paiva B; Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBERONC (CB16/12/00369), Pamplona, Spain., Klein C; Roche Innovation Center Zurich, Switzerland., Umaña P; Roche Innovation Center Zurich, Switzerland.

Publikováno v: Blood [Blood] 2024 Oct 30. Date of Electronic Publication: 2024 Oct 30.

From Malthusian Disequilibrium to the Post-Malthusian Era: The Evolution of the Preventive and Positive Checks in Germany, 1730-1870.

Autor: Pfister U; University of Münster, Institute of Economic and Social History, Domplatz 20-22, 48143, Münster, Germany. pfister@uni-muenster.de., Fertig G; University of Halle-Wittenberg, Institute of History, Steintorcampus, 06099, Halle (Saale), Germany.

Publikováno v: Demography [Demography] 2020 Jun; Vol. 57 (3), pp. 1145-1170.

Conclusions

Autor: Lambrecht, T., Vanhaute, E, Devos, I., Béaur, G., Fertig, G., Gadd, C.J., Karel, E.H.K., Limperger, M., Paping, R.F.J., Schofield, P., Vanhaute, E., Karel, E., Paping, R.

Publikováno v: Making a living. Family, Income and Labour, 323-347
STARTPAGE=323;ENDPAGE=347;TITLE=Making a living. Family, Income and Labour

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::e90765cc9f09905e6ccf36d7246c7d13
https://research.rug.nl/en/publications/e5890c57-7060-4425-b6e6-2755ac343706

Long-term follow up of childhood tuberculous meningitis

Autor: Priscilla Springer, Marlette Burger, J Wait, Peter R. Donald, A Janse van Rensburg, F. Van Zyl, Johan F. Schoeman, Fertig G

Publikováno v: Developmental Medicine & Child Neurology. 44

The purpose of the present study was to determine the long-term outcome of 76 children (40 females and 36 males) diagnosed and treated with modern antituberculosis drugs. The median age of the children on admission was 29.5 months and on follow-up 9

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e6933339a4357b26edf5a1c0c1a3f1b
https://doi.org/10.1017/s0012162201002493

Comparison of Nucleosome, Ferritin and LDH Levels in Blood with Clinical Response before and after Electrochemotherapy Combined with IL-12 Gene Electrotransfer for the Treatment of Mast Cell Tumours in Dogs.

Autor: Vilfan, Maša¹ (AUTHOR) ulampreht@onko-i.si, Lampreht Tratar, Urša^1,2 (AUTHOR) alenka.nemecsvete@vf.uni-lj.si, Milevoj, Nina¹ (AUTHOR), Nemec Svete, Alenka¹ (AUTHOR), Čemažar, Maja^2,3 (AUTHOR) gsersa@onko-i.si, Serša, Gregor² (AUTHOR), Tozon, Nataša¹ (AUTHOR) natasa.tozon@vf.uni-lj.si

Publikováno v: Animals (2076-2615). Feb2024, Vol. 14 Issue 3, p438. 25p.